177 related articles for article (PubMed ID: 9637513)
21. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
Zhang M; Majid A; Bardwell P; Vee C; Davidson A
J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
Cleary J; Glick GD
Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
[TBL] [Abstract][Full Text] [Related]
23. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
Figini M; Marks JD; Winter G; Griffiths AD
J Mol Biol; 1994 May; 239(1):68-78. PubMed ID: 8196048
[TBL] [Abstract][Full Text] [Related]
24. Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.
Potter KN; Thomson RK; Hamblin A; Richards SD; Lindsay JG; Stevenson FK
J Mol Biol; 2001 Feb; 306(1):37-46. PubMed ID: 11178892
[TBL] [Abstract][Full Text] [Related]
25. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
26. Single amino acid substitutions in V(H) CDR2 are sufficient to generate or enhance the specificity of two forms of an anti-arsonate antibody variable region for DNA.
Hande S; Manser T
Mol Immunol; 1997 Dec; 34(18):1281-90. PubMed ID: 9683270
[TBL] [Abstract][Full Text] [Related]
27. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
28. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
29. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
30. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
[TBL] [Abstract][Full Text] [Related]
31. Selection of high affinity p-azophenyarsonate Fabs from heavy-chain CDR2 insertion libraries.
Parhami-Seren B; Viswanathan M; Margolies MN
J Immunol Methods; 2002 Jan; 259(1-2):43-53. PubMed ID: 11730840
[TBL] [Abstract][Full Text] [Related]
32. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
34. Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.
Lambrianides A; Giles I; Ioannou Y; Mason L; Latchman DS; Manson JJ; Isenberg DA; Rahman A
Arthritis Rheum; 2007 Jul; 56(7):2392-401. PubMed ID: 17599767
[TBL] [Abstract][Full Text] [Related]
35. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
36. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
[TBL] [Abstract][Full Text] [Related]
37. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
[TBL] [Abstract][Full Text] [Related]
39. Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin.
Osei A; Uttenreuther-Fischer MM; Lerch H; Gaedicke G; Fischer P
Arthritis Rheum; 2000 Dec; 43(12):2722-32. PubMed ID: 11145030
[TBL] [Abstract][Full Text] [Related]
40. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
